drugset / Trial / NCT02782520

Comparison of the Effects of an Hypertonic Solution With Ringer Lactate on Right Ventricular Function Following Cardiac Surgery

NCT02782520

Phase 3 Completed 30 enrolled University Hospital, Grenoble
RandomizedParallel-groupSingle-blindTreatment

Summary

This study is a phase III, randomized, controled, parallel groups, single blinded, clinical trial that aims at comparing the improvement of right ventricular function after administration of a hypertonic solution versus Ringer Lactate following cardiac surgery. Adults patients admitted to Grenoble University Hospital for elective cardiac surgery under cardiopulmonary bypass, in sinus rhythm and with Swan Ganz monitoring will be included. Patients needing fluid expansion in the first three hours after surgery will be randomized in two groups : one receiving Ringer Lactate (10 mL/kg), the other receiving hypertonic saline solution (3 mL/kg). Right ventricular function measured with Swan Ganz catheter, 30 minutes after fluid expansion will be the primary outcome.

Timeline

Start
2016-08
Primary completion
2017-10
Completion
2017-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 3 unknown
Comparator Ringer lactate Other / unclassified 10 unknown

Indications

No indication recorded.